Axos Financial, Inc.: Form 10-Q for the period ended Dec 31, 2023
Filed with the SEC on Jan 30, 2024 and accepted by EDGAR at Jan 30, 2024, 16:21 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Interest expense | 3 months2023-10-01 to 2023-12-31 | $166.1m | us-gaap:InterestExpense |
| Interest expense | 6 months2023-07-01 to 2023-12-31 | $318.9m | us-gaap:InterestExpense |
| Income tax | 3 months2023-10-01 to 2023-12-31 | $65.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-07-01 to 2023-12-31 | $101.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-10-01 to 2023-12-31 | $151.8m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-07-01 to 2023-12-31 | $234.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-10-01 to 2023-12-31 | $2.62 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-07-01 to 2023-12-31 | $3.98 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-10-01 to 2023-12-31 | $2.65 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-07-01 to 2023-12-31 | $4.04 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-10-01 to 2023-12-31 | 57,216,621 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-07-01 to 2023-12-31 | 58,082,830 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-07-01 to 2023-12-31 | $147.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-07-01 to 2023-12-31 | $17.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 6 months2023-07-01 to 2023-12-31 | $82.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-12-31 | $1.76bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2023-12-31 | $21.62bn | us-gaap:Assets |
| Total liabilities | At period end2023-12-31 | $19.55bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-12-31 | $341.1m | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2023-12-31 | $2.08bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001299709-24-000008. Last ingested by Listed: Nov 5, 2026, 13:51 ET. Listed shows no prices and gives no investment advice.